RPRX

NASDAQRoyalty Pharma Plc
High Tide · 60Squeeze · Idle 25Bullish0 buys · $0Social · Quiet 0
$58.61
$-0.14 (-0.24%)
15-min delayed · Sep 12, 7:41 PMReal-time

Score summary

Strong Buy
Analyst Ratings
6Ratings
6 Buy0 Hold0 Sell
Tide Score
60
High Tide · stable · Top 23% of universe (4003)
Outlook68High Tide · stable · Top 15% of universe (4004)
Squeeze Score
25
Idle ·
  • Days to cover5.05
  • Short interest2.86% of float
  • Borrow rate32.53%
  • Short interest trend+0.14% (30d)
Trend
Bullish
Trending up — 4 of 8 indicators bullish
Recent Smart Money
0 buys
Quiet · $0 · 14d · 5 super investors

Key statistics

Market Cap
$36.96B
52-week range
$34.37 – $63.96
71% from low
Day range
$58 – $60
Open $58.95
Volume
2.6M
vs 2.7M avg · 95%
P/E (TTM)
34.4
Fwd 11.2
Earnings
Nov 4
53d · est $1.18

Country ranks

US RankCountry rank populator pending
BW universe: US & CA common stocks only · ETFs and mutual funds excluded · Methodology →

Price chart with forecast cone and smart-money events

Wall Street Analyst Consensus

Wall Street Analyst Consensus
Aggregate of 6 third-party analyst opinions — not Quantellect advice.
12-mo median price target
$63
6 Wall St 12-month targets
High
$68
Average
$60
Low
$42
$41$48$55$62$69HIGH$68MEDIAN$62.5LOW$42Mar ’26NOW12-mo target
Recent price history, then Wall-Street analysts’ 12-month price targets (high / median / low) shown forward to the 12-month target levels. Targets are third-party analysts’ estimates of future performance — not guarantees, and not Quantellect recommendations. Past results do not guarantee future returns.
Per-analyst ratings are not yet available for this ticker.
Aggregate of third-party analysts’ published opinions, shown for information only — not Quantellect advice. The 75/100 Analyst Score (Strong Buy) is Quantellect’ documented weighting of the rating distribution on the same 0–100 scale as the Tide / Squeeze / Trend / Money scores; the verdict label is derived from that score. Past results do not guarantee future returns. Source: aes.

Why Tide score breakdown

Smart-money feed

Social pulse

Smart-money modules

Catalysts ahead

Catalysts aheadEarnings Nov 4 (post-market, est EPS $1.18) · Annual shareholder meeting Jun 17 · Russell 1000 rebalance Jul 22 · DOJ CUDA hearing window Q3

Drill deeper

Not investment advice. Past results do not guarantee future returns. Scores, narratives, and historical-cohort statistics on this page are generated by Quantellect algorithms from public filings, market data, and AI synthesis, and describe the historical performance of structurally similar setups in our universe; failures are included. Data may be 15-minute delayed, contain errors, or be revised. Always do your own research and consult a licensed financial advisor before making investment decisions.